Subdermal progestin implant and an oral combined hormonal contraceptive in youth with type 1 diabetes
To determine the metabolic effects of the subcutaneous etonogestrel implant compared to an oral contraceptive in adolescents and young adults (AYA) with T1D on body weight, body composition, glucose, lipids, and C-reactive protein levels (CRP).
Source: Journal of Pediatric and Adolescent Gynecology - Category: OBGYN Authors: Franco Giraudo, Abril Salinas, Paulina M Merino, Germ án Iñiguez, Patricia López, Andrea Castro, María Cecilia Lardone, Gabriel Cavada, Fernando Cassorla, Ethel Codner Source Type: research